Biomea Fusion (BMEA) EBT (2020 - 2026)

Biomea Fusion has reported EBT for 7 years, with the latest figure at -$12.3 million in Q1 2026.

• Quarterly EBT rose 57.82% year-over-year to -$12.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.4 million (up 48.43% YoY) and the FY2025 annual result came in at -$214.9 million, up 14.82% from the prior year.
• EBT improved to -$12.3 million in Q1 2026 per BMEA's latest filing, from -$16.9 million in the prior quarter.
• Over five years, EBT peaked at -$12.3 million in Q1 2026 and troughed at -$45.3 million in Q3 2023.
• A 5-year average of -$27.9 million and a median of -$29.3 million in 2025 frame the typical range for EBT.
• The sharpest annual moves came in 2023 and 2026: EBT slumped 145.42% in 2023, then surged 57.82% in 2026.
• Over 5 years, EBT stood at -$25.5 million in 2022, then plunged by 35.3% to -$34.5 million in 2023, then grew by 14.68% to -$29.4 million in 2024, then jumped by 42.56% to -$16.9 million in 2025, then grew by 26.95% to -$12.3 million in 2026.
• According to Business Quant data, EBT over the past three periods registered -$12.3 million, -$16.9 million, and -$16.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.